These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 15934858

  • 1. Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
    Reffelmann T, Kloner RA.
    Expert Opin Drug Saf; 2005 May; 4(3):531-40. PubMed ID: 15934858
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Sex, erectile dysfunction, and the heart: a growing problem].
    Görge G, Flüchter S, Kirstein M, Kunz T.
    Herz; 2003 Jun; 28(4):284-90. PubMed ID: 12825143
    [Abstract] [Full Text] [Related]

  • 6. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
    Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C, Cheitlin M, Debusk R, Fonseca V, Ganz P, Goldstein I, Guay A, Hatzichristou D, Hollander JE, Hutter A, Katz S, Kloner RA, Mittleman M, Montorsi F, Montorsi P, Nehra A, Sadovsky R, Shabsigh R.
    Am J Cardiol; 2005 Jul 15; 96(2):313-21. PubMed ID: 16018863
    [Abstract] [Full Text] [Related]

  • 7. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    Kloner RA.
    Am J Cardiol; 2005 Dec 26; 96(12B):42M-46M. PubMed ID: 16387566
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Update on oral treatments for male erectile dysfunction.
    Kalsi JS, Kell PD.
    J Eur Acad Dermatol Venereol; 2004 May 26; 18(3):267-74. PubMed ID: 15096134
    [Abstract] [Full Text] [Related]

  • 14. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM, Iltz JL, Fincham JE, Campbell RK, Baker DE.
    Ann Pharmacother; 2005 May 26; 39(7-8):1286-95. PubMed ID: 15941818
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Update of PDE5 inhibitors as treatment of ED].
    Lu YN, Chen B.
    Zhonghua Nan Ke Xue; 2005 Jul 26; 11(7):552-5. PubMed ID: 16078679
    [Abstract] [Full Text] [Related]

  • 17. [Sildenafil--adverse effects, complications and safety].
    Sperling H, Michel MC.
    Wien Klin Wochenschr; 2002 Jan 15; 114(1-2):4-6. PubMed ID: 12407928
    [No Abstract] [Full Text] [Related]

  • 18. Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.
    Kloner RA.
    Circulation; 2004 Nov 09; 110(19):3149-55. PubMed ID: 15533876
    [No Abstract] [Full Text] [Related]

  • 19. Appropriate use of exercise testing prior to administration of drugs for treatment of erectile dysfunction.
    Arruda-Olson AM, Pellikka PA.
    Herz; 2003 Jun 09; 28(4):291-7. PubMed ID: 12825144
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.